-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Zika virus (ZIKV) is a mosquito-borne RNA virus belonging to the Flaviviridae family
Recently, Zhang Jiancun's research group from Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, and Yuan Jie's research group from Sun Yat-Sen University have designed and synthesized a series of new nucleoside inhibitors for ZIKV, and obtained candidate drugs that can inhibit ZIKV
RNA-dependent RNA polymerase (RdRp) has always been a popular target for antiviral drugs, and nucleoside analogs can target viral RdRp and incorporate nascent RNA strands to terminate viral RNA replication
This study designed, synthesized and evaluated the inhibitory activity and structure-activity relationship (SAR) of a series of novel 6-methyl-7-ethynyl-7-deazapurine nucleoside analogs against ZIKV
Researcher Zhang Jiancun and Associate Professor Yuan Jie are the co-corresponding authors of the paper
Paper link
Guangzhou Health Center has made progress in the research of nucleoside anti-Zika virus drugs